Plan Term Earlier Termination or Suspension of the Plan Clause Example from Business Contracts
This example Plan Term Earlier Termination or Suspension of the Plan clause appears in 91 contracts from 62 companies
2019 Equity Incentive Plan (Filed With SEC on February 4, 2019)
2019 Equity Incentive Plan (Filed With SEC on January 18, 2019)
Yelp Inc. 2012 Equity Incentive Plan, as Amended (Filed With SEC on February 13, 2019)
YELP INC. 2012 EQUITY INCENTIVEPLAN (Filed With SEC on September 23, 2016)
Cirius Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on January 11, 2019)
2019 Equity Incentive Plan and forms of grant notice, stock option and restricted stock unit award agreements and notice of exercise thereunder (Filed With SEC on January 29, 2019)
Harpoon Therapeutics, Inc. 2019 Equity Incentive Plan and related form agreements (Filed With SEC on August 10, 2022)
2019 Equity Incentive Plan (Filed With SEC on February 13, 2019)
HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)
HTG MOLECULAR DIAGNOSTICS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 2, 2014 AMENDED BY THE BOARDOF DIRECTORS: APRIL 23, 2015 APPROVED BYTHE... (Filed With SEC on April 28, 2015)
Portola Pharmaceuticals, Inc. 2013 Equity Incentive Plan and Amendment dated February 27, 2019 (Filed With SEC on May 8, 2019)
PORTOLA PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 30, 2013 AMENDED BY THE BOARDOF DIRECTORS: FEBRUARY 27, 2013 APPROVED BYTHE... (Filed With SEC on April 12, 2013)
Castle Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on June 26, 2019)
Castle Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on July 15, 2019)
Personalis, Inc. 2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 7, 2019)
Turning Point Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise (Filed With SEC on April 8, 2019)
2019 Equity Incentive Plan (Filed With SEC on April 29, 2019)
2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 10, 2019)
RAPT Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
Vir Biotechnology, Inc. 2019 Equity Incentive Plan (Filed With SEC on September 30, 2019)
Vir Biotechnology, Inc. 2019 Equity Incentive Plan (Filed With SEC on September 3, 2019)
Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, to be in effect when this registration statement is declared effective (Filed With SEC on July 8, 2019)
UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 10, 2020)
UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 8, 2021)
2018 Equity Incentive Plan (as amended December 2020 (Filed With SEC on March 16, 2021)
2018 Equity Incentive Plan and Forms of Stock Option Grant Notice and Agreement and Restricted Stock Unit Grant Notice and Agreement thereunder (Filed With SEC on October 5, 2018)
2018 Equity Incentive Plan (Filed With SEC on November 6, 2018)
Form of 2018 Equity Incentive Plan (to be effective upon the closing of this offering) (Filed With SEC on May 31, 2018)
Synthorx, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock... (Filed With SEC on November 27, 2018)
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit... (Filed With SEC on October 2, 2018)
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on October 2, 2018)
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 17, 2018)
Bionano Genomics, Inc. 2018 Equity Incentive Plan (the 2018 Plan) (Filed With SEC on July 17, 2018)
Bionano Genomics, Inc. 2018 Equity Incentive Plan (the 2018 Plan) (Filed With SEC on August 15, 2018)
CymaBay Therapeutics, Inc. amended and restated 2013 Equity Incentive Plan (Filed With SEC on June 7, 2018)
CYMABAY THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 25, 2013 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2013 EFFECTIVE DATE:... (Filed With SEC on June 6, 2014)
Adaptive Insights, Inc. 2018 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 1, 2018)
Everspin Technologies, Inc. Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on May 22, 2018)
EVERSPIN TECHNOLOGIES, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 25, 2016 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 20, 2016 IPO DATE: , 2016 (Filed With SEC on September 26, 2016)
EVERSPIN TECHNOLOGIES, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 25, 2016 APPROVED BY THE STOCKHOLDERS:[ ] IPO DATE: [ ] (Filed With SEC on September 9, 2016)
2018 Equity Incentive Plan (Filed With SEC on May 24, 2018)
2018 Equity Incentive Plan and Forms of Stock Option Grant Notice and Agreement and Restricted Stock Unit Grant Notice and Agreement thereunder (Filed With SEC on June 29, 2018)
Form of 2018 Equity Incentive Plan (Filed With SEC on June 5, 2018)
2018 Equity Incentive Plan, to be in effect immediately prior to the effectiveness of this registration statement (Filed With SEC on May 2, 2018)
Xencor, Inc. 2013 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder (Filed With SEC on February 28, 2018)
XENCOR, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: NOVEMBER 1, 2013 APPROVED BY THE STOCKHOLDERS: , 2013 IPO DATE: , 2013 (Filed With SEC on November 4, 2013)
XENCOR, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2013 APPROVED BY THE STOCKHOLDERS: , 2013 IPO DATE: , 2013 (Filed With SEC on October 11, 2013)
2018 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice thereunder (Filed With SEC on January 29, 2018)
SNAP INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: January 27,2017 APPROVED BY THE STOCKHOLDERS: February 2, 2017 IPO DATE: , 2017 (Filed With SEC on February 2, 2017)
MobileIron, Inc. Amended and Restated 2014 Equity Incentive Plan Adopted by the Board of Directors: April 17, 2014 Approved by the Stockholders: May 27, 2014 IPO Date/Effective... (Filed With SEC on July 29, 2016)
MOBILE IRON, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 17, 2014 APPROVED BY THE STOCKHOLDERS: , 2014 IPODATE/EFFECTIVE DATE: [ ], 2014 (Filed With SEC on April 23, 2014)
MOBILEIRON, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 17, 2014 APPROVED BY THE STOCKHOLDERS:MAY 27, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on May 29, 2014)
EASIC CORPORATION 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 18, 2015 APPROVED BY THE STOCKHOLDERS:[ ], 2015 IPO DATE:[ ], 2015 (Filed With SEC on February 19, 2015)
INTERSECT ENT, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY, 2014 APPROVED BY THE STOCKHOLDERS:[ ], 2014 IPO DATE/EFFECTIVEDATE: [ ], 2014 (Filed With SEC on July 9, 2014)
INTERSECT ENT, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 7, 2014 APPROVED BY THE STOCKHOLDERS:JULY 10, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on July 14, 2014)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 AMENDED BY THE BOARD OFDIRECTORS: SEPTEMBER 11, 2013 APPROVED BY... (Filed With SEC on January 22, 2014)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 AMENDED BY THE BOARD OFDIRECTORS: SEPTEMBER 11, 2013 APPROVED BY... (Filed With SEC on November 1, 2013)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 APPROVED BY THE STOCKHOLDERS:OCTOBER 10, 2013 IPO DATE: ,2013 (Filed With SEC on October 11, 2013)
ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: , 2014 IPO DATE/EFFECTIVE DATE: , 2014 (Filed With SEC on March 5, 2014)
ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2014 IPO DATE/EFFECTIVE DATE:... (Filed With SEC on April 7, 2014)
TRACON PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: JANUARY 1, 2015 APPROVED BY THE STOCKHOLDERS: [], 2015 IPO DATE: [], 2015 (Filed With SEC on January 20, 2015)
BELLICUM PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ], 2014 APPROVED BYTHE STOCKHOLDERS: [ ], 2014 IPODATE: [ ], 2014 (Filed With SEC on November 18, 2014)
EverydayHealth, Inc. 2014Equity Incentive Plan Adoptedby the Board of Directors: March 12, 2014 Approved by the Stockholders: March 12, 2014 IPO Date/Effective Date: _________,... (Filed With SEC on March 17, 2014)
ALTHEADX, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 19, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 22, 2015 IPO DATE: [],2015 (Filed With SEC on January 23, 2015)
ALTHEADX, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2014 APPROVED BY THESTOCKHOLDERS: [], 2014 IPO DATE:[], 2014 (Filed With SEC on December 23, 2014)
FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: JANUARY 27, 2014 (Filed With SEC on January 29, 2014)
FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE: , 2013 (Filed With SEC on January 8, 2014)
AUSPEX PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 15, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 16, 2014 IPO DATE: , 2014 (Filed With SEC on January 17, 2014)
Auspex Pharmaceuticals, Inc. 2014 Equity Incentive Plan Adopted by the Board of Directors: January 15, 2014 Approved by the Stockholders: January 16, 2014 IPO Date: February 4,... (Filed With SEC on March 16, 2015)
ALDER BIOPHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 31, 2014 APPROVED BY THE STOCKHOLDERS:APRIL 7, 2014 IPO DATE/EFFECTIVE DATE: ,... (Filed With SEC on April 25, 2014)
CONTRAFECT CORPORATION 2014 OMNIBUS INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: April 29, 2014 APPROVED BY THE STOCKHOLDERS: [], 2014 IPO DATE/EFFECTIVE DATE: [], 2014 (Filed With SEC on July 1, 2014)
CALITHERA BIOSCIENCES, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 18, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 19, 2014 IPO DATE: , 2014 (Filed With SEC on September 25, 2014)
NEW RELIC, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:NOVEMBER 25, 2014 APPROVED BY THE STOCKHOLDERS:[], 2014 IPO DATE: [], 2014 (Filed With SEC on December 1, 2014)
REVANCE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 22, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 23, 2014 IPO DATE/EFFECTIVE DATE:[ ],... (Filed With SEC on January 27, 2014)
ARIOSA DIAGNOSTICS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL , 2014 APPROVED BY THESTOCKHOLDERS: APRIL , 2014 IPO DATE: , 2014 (Filed With SEC on April 16, 2014)
ALARM.COM HOLDINGS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JUNE , 2015 APPROVED BY THESTOCKHOLDERS: JUNE , 2015 IPO DATE/EFFECTIVEDATE: JUNE , 2015 (Filed With SEC on June 11, 2015)
EAGLE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 201 APPROVED BY THE STOCKHOLDERS: , 201 IPO DATE: , 201 (Filed With SEC on January 22, 2014)
CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2015 APPROVED BY THESTOCKHOLDERS: [], 2015 IPO DATE:[], 2015 (Filed With SEC on March 13, 2015)
CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 27, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE: [],2015 (Filed With SEC on April 6, 2015)
INSTRUCTURE, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 5, 2015 APPROVED BY THE STOCKHOLDERS:OCTOBER 30, 2015 IPO DATE: [ ], 2015 (Filed With SEC on November 2, 2015)
INSTRUCTURE, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 5, 2015 APPROVED BY THE STOCKHOLDERS:[ ], 2015 IPO DATE: [ ], 2015 (Filed With SEC on October 9, 2015)
SYNCARDIA SYSTEMS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JUNE 18, 2015 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 14, 2015 (Filed With SEC on September 16, 2015)
Stitch Fix, Inc. 2017 Incentive Plan (Filed With SEC on November 6, 2017)
OVID THERAPEUTICS INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BYTHE STOCKHOLDERS: , 2017 IPODATE: , 2017 (Filed With SEC on April 18, 2017)
Form of 2017 Equity Incentive Plan (Filed With SEC on October 30, 2017)
APPIAN CORPORATION 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BY THE STOCKHOLDERS: , 2017 IPODATE: , 2017 (Filed With SEC on May 10, 2017)
Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 27, 2013)
Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 8, 2013)
AMBIT BIOSCIENCES CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 12, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE/EFFECTIVE DATE: , 2013 (Filed With SEC on February 20, 2013)
AMBIT BIOSCIENCES CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 12, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE/EFFECTIVE DATE: , 2013 (Filed With SEC on April 25, 2013)
